Determining the Primary Endpoint for a Stimulant Abuse Trial: Lessons Learned from STRIDE (CTN 0037)

REFERENCES

• Dutra L, Stathopoulou G, Basden SL, Leyro TM, Powers MB, Otto MW. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry 2008; 165(2):179–187.
   PubMed Web of Science ®Google Scholar
• Carroll KM, Ball SA, Nich C, Martino S, Frankforter TL, Farentinos C, Kunkel LE, Mikulich-Gilbertson SK, Morgenstern J, Obert JL, Polcin D, Snead N, Woody GE. Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: A multisite effectiveness study. Drug Alcohol Depend 2006; 81(3):301–312.
   PubMed Web of Science ®Google Scholar
• Rawson RA, McCann MJ, Flammino F, Shoptaw S, Miotto K, Reiber C, Ling W. A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individuals. Addiction 2006; 101(2):267–274.
   PubMed Web of Science ®Google Scholar
• Wetzel H, Szegedi A, Scheurich A, Lorch B, Singer P, Schlafke D, Sittinger H, Wobrock T, Muller MJ, Anghelescu I, Hautzinger M. Combination treatment with nefazodone and cognitive-behavioral therapy for relapse prevention in alcohol-dependent men: A randomized controlled study. J Clin Psychiatry 2004; 65(10):1406–1413.
   PubMed Web of Science ®Google Scholar
• Ball SA, Martino S, Nich C, Frankforter TL, Van Horn D, Crits-Christoph P, Woody GE, Obert JL, Farentinos C, Carroll KM. Site matters: Multisite randomized trial of motivational enhancement therapy in community drug abuse clinics. J Consult Clin Psychol 2007; 75(4):556–567.
   PubMed Web of Science ®Google Scholar
• Fals-Stewart W, O’Farrell TJ, Freitas TT, McFarlin SK, Rutigliano P. The timeline followback reports of psychoactive substance use by drug-abusing patients: Psychometric properties. J Consult Clin Psychol 2000; 68(1):134–144.
   PubMed Web of Science ®Google Scholar
• Preston KL, Silverman K, Schuster CR, Cone EJ. Assessment of cocaine use with quantitative urinalysis and estimation of new uses. Addiction 1997; 92(6):717–727.
   PubMed Web of Science ®Google Scholar
• Gerstein DR. Outcome research – drug abuse. In American Psychiatric Press Textbook of Substance Abuse Treatment. Galanter M, Kleber HD, eds. Washington, DC: American Psychiatric Press, 1999.
   Google Scholar
• Lavori PW, Bloch DA, Bridge PT, Leiderman DB, LoCastro JS, Somoza E. Plans, designs, and analyses for clinical trials of anti-cocaine medications: Where we are today. NIDA/VA/SU Working Group on Design and Analysis. J Clin Psychopharmacol 1999; 19(3):246–256.
   PubMed Web of Science ®Google Scholar
• Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE. Measures of abstinence in clinical trials: Issues and recommendations. Nicotine Tob Res 2003; 5(1):13–25.
   PubMed Web of Science ®Google Scholar
• Higgins ST, Budney AJ, Bickel WK, Hughes JR, Foerg F, Badger G. Achieving cocaine abstinence with a behavioral approach. Am J Psychiatry 1993; 150(5The Clinical Trials Network: A Decade of Progress (Guest Editor: Edward Nunes)):763–769.
   PubMed Web of Science ®Google Scholar
• Petry NM, Peirce JM, Stitzer ML, Blaine J, Roll JM, Cohen A, Obert J, Killeen T, Saladin ME, Cowell M, Kirby KC, Sterling R, Royer-Malvestuto C, Hamilton J, Booth RE, Macdonald M, Liebert M, Rader L, Burns R, DiMaria J, Copersino M, Stabile PQ, Kolodner K, Li R. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: A national drug abuse treatment clinical trials network study. Arch Gen Psychiatry 2005; 62(10):1148–1156.
   PubMed Web of Science ®Google Scholar
• Allen JP. Measuring outcome in interventions for alcohol dependence and problem drinking: Executive summary of a conference sponsored by the national institute on alcohol abuse and alcoholism. Alcohol Clin Exp Res 2003; 27(10):1657–1660.
   PubMed Web of Science ®Google Scholar
• Anton RF, Randall CL. Measurement and choice of drinking outcome variables in the COMBINE study. J Stud Alcohol Drugs Suppl 2005; 15:104–109.
   Google Scholar
• Babor TF, Steinberg K, Anton R, Del Boca F. Talk is cheap: Measuring drinking outcomes in clinical trials. J Stud Alcohol 2000; 61(1):55–63.
   PubMed Web of Science ®Google Scholar
• Del Boca F, Noll JA. Truth of consequences: The validity of self-report data in health services research on addictions. Addiction 2000; 95(Suppl. 3):S347–S360.
   PubMed Web of Science ®Google Scholar
• Finney JW, Moyer A, Swearingen CE, Variables O. Their assessment in alcohol treatment studies: 1968–1998. Alcohol Clin Exp Res 2003; 27(10):1671–1679.
   PubMed Web of Science ®Google Scholar
• Miller PG, Miller WR. What should we be aiming for in the treatment of addiction? Addiction 2009; 104:685–686.
   PubMed Web of Science ®Google Scholar
• Silverman K, Robles E, Mudric T, Bigelow GE, Stitzer ML. A randomized trial of long-term reinforcement of cocaine abstinence in methadone-maintained patients who inject drugs. J Consult Clin Psychol 2004; 72(5The Clinical Trials Network: A Decade of Progress (Guest Editor: Edward Nunes)):839–854.
   PubMed Web of Science ®Google Scholar
• Silverman K, Higgins ST, Brooner RK, Montoya ID, Cone EJ, Schuster CR, Preston KL. Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy. Arch Gen Psychiatry 1996; 53(5The Clinical Trials Network: A Decade of Progress (Guest Editor: Edward Nunes)):409–415.
   PubMed Web of Science ®Google Scholar
• Kirby KC, Marlowe DB, Festinger DS, Lamb RJ, Platt JJ. Schedule of voucher delivery influences initiation of cocaine abstinence. J Consult Clin Psychol 1998; 66(5The Clinical Trials Network: A Decade of Progress (Guest Editor: Edward Nunes)):761–767.
   PubMed Web of Science ®Google Scholar
• Petry NM, Martin B, Simcic F, Jr. Prize reinforcement contingency management for cocaine dependence: Integration with group therapy in a methadone clinic. J Consult Clin Psychol 2005; 73(2):354–359.
   PubMed Web of Science ®Google Scholar
• McKee SA, Carroll KM, Sinha R, Robinson JE, Nich C, Cavallo D, O’Malley S. Enhancing brief cognitive-behavioral therapy with motivational enhancement techniques in cocaine users. Drug Alcohol Depend 2007; 91(1):97–101.
   PubMed Web of Science ®Google Scholar
• Carroll KM, Rounsaville BJ, Gordon LT, Nich C, Jatlow P, Bisighini RM, Gawin FH. Psychotherapy and pharmacotherapy for ambulatory cocaine abusers. Arch Gen Psychiatry 1994; 51(3):177–187.
   PubMed Web of Science ®Google Scholar
• Baker A, Lee NK, Claire M, Lewin TJ, Grant T, Pohlman S, Saunders JB, Kay-Lambkin F, Constable P, Jenner L, Carr VJ. Brief cognitive behavioural interventions for regular amphetamine users: A step in the right direction. Addiction 2005; 100(3):367–378.
   PubMed Web of Science ®Google Scholar
• Somoza E, Somoza P, Lewis D, Li SH, Winhusen T, Chiang N, Vocci F, Horn P, Elkashef A. The SRPHK1 outcome measure for cocaine-dependence trials combines self-report, urine benzoylecgonine levels, and the concordance between the two to determine a cocaine-use status for each study day. Drug Alcohol Depend 2008; 93(1–2):132–140.
   PubMed Web of Science ®Google Scholar
• Carroll KM, Fenton LR, Ball SA, Nich C, Frankforter TL, Shi J, Rounsaville BJ. Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: A randomized placebo-controlled trial. Arch Gen Psychiatry 2004; 61(3):264–272.
   PubMed Web of Science ®Google Scholar
• Marcus BH, Albrecht AE, King TK, Parisi AF, Pinto BM, Roberts M, Niaura RS, Abrams DB. The efficacy of exercise as an aid for smoking cessation in women: A randomized controlled trial. Arch Intern Med 1999; 159(11):1229–1234.
   PubMedGoogle Scholar
• Martin JE, Calfas KJ, Patten CA, Polarek M, Hofstetter CR, Noto J, Beach D. Prospective evaluation of three smoking interventions in 205 recovering alcoholics: One-year results of Project SCRAP-Tobacco. J Consult Clin Psychol 1997; 65(1):190–194.
   PubMed Web of Science ®Google Scholar
• Marcus BH, Lewis BA, Hogan J, King TK, Albrecht AE, Bock B, Parisi AF, Niaura R, Abrams DB. The efficacy of moderate-intensity exercise as an aid for smoking cessation in women: A randomized controlled trial. Nicotine Tob Res 2005; 7(6):871–880.
   PubMed Web of Science ®Google Scholar
• Carroll KM, Nich C, Ball SA, McCance E, Rounsavile BJ. Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction 1998; 93(5The Clinical Trials Network: A Decade of Progress (Guest Editor: Edward Nunes)):713–727.
   PubMed Web of Science ®Google Scholar
• Sobell LC, Sobell MB. Timeline follow-back: A technique for assessing self-reported alcohol consumption. In Measuring Alcohol Consumption: Psychosocial and Biological Methods. Litten RZ, Allen JP, eds. Totowa, NJ: Humana Press, 1992; 41–72.
   Google Scholar
• Nunes EV, McGrath PJ, Quitkin FM, Ocepek-Welikson K, Stewart JW, Koenig T, Wager S, Klein DF. Imipramine treatment of cocaine abuse: Possible boundaries of efficacy. Drug Alcohol Depend 1995; 39(3):185–195.
   PubMed Web of Science ®Google Scholar
• Nunes EV, Quitkin FM, Donovan SJ, Deliyannides D, Ocepek-Welikson K, Koenig T, Brady R, McGrath PJ, Woody G. Imipramine treatment of opiate-dependent patients with depressive disorders. A placebo-controlled trial. Arch Gen Psychiatry 1998; 55(2):153–160.
   PubMed Web of Science ®Google Scholar
• Magura S, Kang SY. Validity of self-reported drug use in high risk populations: A meta-analytical review. Subst Use Misuse 1996; 31(9):1131–1153.
   PubMed Web of Science ®Google Scholar
• Hersh D, Mulgrew CL, Van Kirk J, Kranzler HR. The validity of self-reported cocaine use in two groups of cocaine abusers. J Consult Clin Psychol 1999; 67(1):37–42.
   PubMed Web of Science ®Google Scholar
• Shiffman S. How many cigarettes did you smoke? Assessing cigarette consumption by global report, time-line follow-back, and ecological momentary assessment. Health Psychol 2009; 28(5The Clinical Trials Network: A Decade of Progress (Guest Editor: Edward Nunes)):519–526.
   PubMed Web of Science ®Google Scholar
• McLellan AT, Luborsky L, Woody GE, O’Brien CP. An improved diagnostic evaluation instrument for substance abuse patients. The addiction severity index. J Nerv Ment Dis 1980; 168(1):26–33.
   PubMed Web of Science ®Google Scholar
• Cacciola JS, Alterman AI, McLellan AT, Lin YT, Lynch KG. Initial evidence for the reliability and validity of a “Lite” version of the addiction severity index. Drug Alcohol Depend 2007; 87(2–3):297–302.
   PubMed Web of Science ®Google Scholar
• Winhusen TM, Somoza EC, Singal B, Kim S, Horn PS, Rotrosen J. Measuring outcome in cocaine clinical trials: A comparison of sweat patches with urine toxicology and participant self-report. Addiction 2003; 98(3):317–324.
   PubMed Web of Science ®Google Scholar
• Hawks RL, Chiang CN. Examples of specific drug assays. NIDA Res Monogr 1986; 73:84–112.
   PubMedGoogle Scholar
• Daniel CR, III, Piraccini BM, Tosti A. The nail and hair in forensic science. J Am Acad Dermatol 2004; 50(2):258–261.
   PubMed Web of Science ®Google Scholar
• Rollins DE, Wilkins DG, Krueger GG, Augsburger MP, Mizuno A, O’Neal C, Borges CR, Slawson MH. The effect of hair color on the incorporation of codeine into human hair. J Anal Toxicol 2003; 27:545–551.
   PubMed Web of Science ®Google Scholar
• Blank DL, Kidwell DA. External contamination of hair by cocaine: An issue in forensic interpretation. Forensic Sci Int 1993; 63:145–156.
   PubMed Web of Science ®Google Scholar
• Wang WL, Cone EJ. Testing human hair for drugs of abuse. IV. Environmental cocaine contamination and washing effects. Forensic Sci Int 1995; 70:39–51.
   PubMed Web of Science ®Google Scholar
• Miller WR, Manuel JK. How large must a treatment effect be before it matters to practitioners? An estimation method and demonstration. Drug Alcohol Rev 2008; 27(5The Clinical Trials Network: A Decade of Progress (Guest Editor: Edward Nunes)):524–528.
   PubMed Web of Science ®Google Scholar